1 Airway remodelling occurs in asthma and involves an increase in airway smooth muscle mass through cell proliferation and hypertrophy. Increased eosinophil density in the airways is a feature of asthma. Eosinophils exhibiting activation in the airways of asthmatics also exhibit increased expression of transforming growth factor beta (TGF-b1). We have examined the capacity of TGF-b1 and epidermal growth factor (EGF) to in¯uence airway smooth muscle division and the e ect of heparin on TGF-b1, EGF and serum-induced smooth muscle DNA synthesis in con¯uent airway smooth muscle cells (ASMC) as an indication of entry into S phase preceding mitogenesis. 2 ASMC were obtained from cell populations growing out from explanted bovine trachealis muscle sections. Cell division was monitored in sparse plated cells by direct cell counting following nuclear staining. Cell DNA synthesis in con¯uent cells was monitored by uptake of [ 3 H]-thymidine. 3 TGF-b1 (100 pM) inhibited FBS (10%)-induced smooth muscle division in sparsely plated cells (40%). TGF-b1 (100 pM) increased cell DNA synthesis (200%) in con¯uent cells in the presence of bovine serum albumin (BSA, 0.25%). EGF (0.7 nM) also increased airway smooth muscle DNA synthesis (69%) in the presence of BSA (0.25%). The facilitatory e ect of TGF-b1 was observed between 1 ± 100 pM, while that of EGF was observed between 20 ± 200 pM. 4 Heparin inhibited serum and TGF-b1-induced DNA synthesis in con¯uent ASMC (55%), consistent with our previous observation of inhibition of division in sparsely populated ASMC (Kilfeather et al., 1995a). This action of heparin was observed between concentrations of 1 ± 100 mg ml 71 . Heparin did not inhibit DNA synthesis in response to EGF. An anti-mitogenic e ect of heparin was also observed against responses to combined exposure to TGF-b1 and EGF. 5 There was a clear inhibitory e ect of heparin in absolute terms against serum-induced division in cells plated at 10, 20 and 45610 3 cells cm 72 . The inhibitory e ect of heparin was also observed at a plating density of 45,000 cells cm 72 when responses to serum were expressed as fold-stimulation of basal DNA synthesis. 6 These ®ndings demonstrate a potential role of TGF-b1, EGF and heparin-related molecules in regulation of airway smooth muscle division.
Inhaled PGF2 alpha and PGE2 were evaluated for relative tussive activity to non-prostanoid tussive agents. In addition a comparison was sought between the present observations and those in the cat, the only laboratory animal which consistently coughs to prostanoids. Five healthy volunteers were repeatedly challenged at 90 min intervals with aerosols of PGE2 (100-500 micrograms ml-1) and tussive activity was monitored. In a second separate study again monitoring tussive activity 10 healthy volunteers inhaled aerosols of either PGF2 alpha (0.1-100 micrograms ml-1), PGE2 (0.1-100 micrograms ml-1), acetylcholine (0.1-50 mg ml-1) or citric acid (5-20% w/v) in a randomised procedure. Objective measurement of tussive activity was achieved using a throat microphone linked via a discriminator to a pen recorder. All four compounds produced two distinct phases of tussive activity, an early phase during challenge and a late phase 1-15 min post-challenge. Repeated challenges with PGE2, produced significant (P less than 0.01) tachyphylaxis to the late phase responses only. Both PGF2 alpha and PGE2 were approximately 1000 and 10,000 times more potent than acetylcholine and citric acid respectively for both phases of tussive activity. Tussive activity was accompanied with retrosternal soreness and tightness of the chest for PGE2, increased sputum for PGF2 alpha, and sore throats with citric acid. Although a correlation exists for man and cat with regards to the tussive potency and the early and late phases of PGF2 alpha activity no such correlation seems to exist for PGE2. The high tussive potency of the prostaglandins in man suggest that their local release in various respiratory pathophysiological conditions may be responsible for the accompanying coughs/irritancy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.